Company news
Jianmin Pharmaceutical Group Co Ltd. news in 2024
Jianmin Pharmaceutical Group Co Ltd.'s news releases, calls and decks from 2024, newest first.
Announcement on Resolution of the 30th Meeting of the 10th Board of Directors
December 17, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
December 12, 2024
Announcement on Inclusion and Renewal of the Company's Products on the Catalogue of Drugs for Basic National Medical Insurance (2024)
November 28, 2024
Notice on Convening the 2nd Extraordinary General Meeting in 2024
November 26, 2024
Announcement on Election of Director to Act as Chairman
October 18, 2024
Announcement on Holding the Performance Briefing for Q3 2024
October 11, 2024
Announcement on Resolution of the 1st Extraordinary General Meeting in 2024
September 30, 2024
Announcement on the Second Unlocking of Restricted Stock Involved in the 2022 Restricted Stock Incentive Plan
September 13, 2024
Announcement on Obtaining the Drug Registration Certificate
August 27, 2024
2024 Semi-annual Report Full Text
August 15, 2024
Announcement on Convening Semi-annual Performance Briefing 2024
August 8, 2024
Announcement on Obtaining the "Drug Registration Certificate"
July 5, 2024
Announcement on 3rd Release and Circulation of Restricted Shares Involved in "2021 Restricted Shares Incentive Plan"
May 24, 2024
Announcement on Implementation of Providing Guarantees for Subsidiaries' Bank Credit Lines
May 14, 2024
Announcement on Attending Online Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction in 2024
May 10, 2024
Announcement on Implementation of Dividend Distribution of 2023
April 19, 2024
Announcement on Marketing Approval of Terbutaline Sulfate Nebuliser Solution
April 15, 2024
Announcement on Resolutions of 2023 Annual General Meeting
April 8, 2024
2023 Annual Report
March 15, 2024